About
A research supplier, documented in public
Vyroval supplies research compounds and publishes a journal about them. This page describes what the site actually contains — the catalogue, the documentation practice, and the limits we work within. It deliberately contains no address, registration number or phone line, because none of those are verifiable from this site.
What the catalogue is
54 compounds across 6 categories — anabolic steroids, peptides, GLP-1 agonists, ancillaries and devices, blends, and SARMs. Every product page carries a CAS number where one is assigned, molecular formula and weight, form, packaging and storage conditions, and states plainly when a CAS number is not assigned rather than borrowing one from a related compound.
Category routes are static pages: steroids, peptides, GLP-1, ancillaries, blends and SARMs.
How batches are documented
Each batch ships against a certificate of analysis: identity by retention against a reference standard, purity by peak area with the method and wavelength stated, and mass confirmation where the compound ionises cleanly. Batches are not pooled — two vials bought months apart carry different lot numbers. The quality page describes the verification sequence; the COA page explains how to request a batch document and what to check when it arrives.
The journal
85 articles, organised into 9 research hubs, plus 1 compound pillar (BPC-157). Citations link to PubMed where an indexed record exists; regulatory and other non-indexed sources name the issuing body and the original document. The editorial byline is institutional — Vyroval Research Desk — and the authors page explains exactly what that means, including how corrections are handled.
What this site does not claim
- Nothing here is a medicinal product, a dosing protocol or a clinical recommendation. Every compound is sold for laboratory research use only.
- Approval status differs by jurisdiction and changes over time; pages state the regulatory record where one exists rather than implying approval.
- No human efficacy claim is made for any compound. Where the literature is preclinical, the pages say so.
Contact
The desk works by email and Telegram. See the contact page for channels, what to include in a first message, and the response window.